HB 349 Kentucky House · 2023 Regular Session

AN ACT relating to the treatment of sexually transmitted diseases.

Summary
Amend KRS 214.430 to permit expedited partner therapy for sexually transmitted infections including but not limited to trichomoniasis, gonorrhea, or chlamydia infection; amend KRS 311.990 to remove the penalty of a Class D felony for a person who donates organs, skin, or other human tissue while being positive for the human immunodeficiency virus; create a new section of KRS Chapter 214 to provide that nothing in KRS 214.181, 214.265, or 214.995 shall be construed to prohibit a person from obtaining or performing a self-test to detect human immunodeficiency virus infection; amend KRS 367.175 to allow for the sale, delivery, holding, or offering for sale of human immunodeficiency virus self-testing kits.
Bill status signed all 5 stages cleared
Introduction
Feb 2023
Committee Review
Mar 2023
House Passage
Mar 2023
Senate Passage
Mar 2023
Signed into Law
Mar 2023
Introduced Feb 16, 2023 Signed Mar 31, 2023
Floor votes · House Mar 7, 2023

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
24
Key actions
7
Committee
6
Mar 31, 2023
Signed into law
signed by Governor (Acts Ch. 150)
lower
Mar 30, 2023
Upper · Passed
enrolled, signed by President of the Senate
upper
Mar 30, 2023
Lower · Passed
enrolled, signed by Speaker of the House
lower
Mar 30, 2023
Lower · Passed
3rd reading, passed 36-1
lower
Mar 15, 2023
Lower · Passed
reported favorably, to Rules as a consent bill
lower
Mar 10, 2023
Committee
to Health Services (S)
upper
Mar 8, 2023
Committee
to Committee on Committees (S)
upper
Mar 7, 2023
Lower · Passed
3rd reading, passed 98-0
lower
Mar 2, 2023
Lower · Passed
reported favorably, 1st reading, to Calendar
lower
Feb 24, 2023
Committee
to Health Services (H)
lower
Feb 16, 2023
Committee
to Committee on Committees (H)
lower
Feb 16, 2023
Introduced
introduced in House
lower
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.